Matinas BioPharma to implement 1-for-15 reverse stock split
Matinas BioPharma approved a one-for-fifteen reverse stock split of its common stock effective Sept. 28, 2026.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.